Using lead as a coolant could save us from a nuclear catastrophe.

From persevering with a tricky Alzheimer’s program to securing a late-stage CD38-directed antibody and posting encouraging lupus data, Biogen has remained in the news recently—and that’s no accident.

June 26 (Reuters) - Biogen said on Friday it had either paused or discontinued funding for most of Apellis Pharmaceuticals' research programs as it integrates the rare-disease drugs specialist it ...

The scientific community has a plan for achieving fusion power. It involves getting a better understanding of how to control fusion in a tokamak-style reactor using the currently under construction ...

Audio is becoming an increasingly important area of focus in pharma marketing, and now four big drugmakers have become sponsors of a new podcast focused on Alzheimer’s disease (AD). Eli Lilly, Biogen, ...

June 17 (Reuters) - Biogen (BIIB.O), opens new tab has struck a deal to acquire private biotechnology company RayThera for ‌up to $1 billion, the companies said on Wednesday, as the U.S.-listed ...

American Fusion Inc. has finalized the testing protocol for its 5 MW pre-production Texatron ...

As a disruptive new nuclear power project embeds itself in Parsons, Kansas, residents are divided on whether it’s worth the potential risk. Parsons, Kansas, is larger than the “haphazard hamlet” ...

Antares Nuclear, Inc. announced Thursday that its Mark-0 microreactor achieved criticality at Idaho National Laboratory, becoming the first advanced reactor to reach the milestone under a U.S.

CAMBRIDGE, Mass. and SAN DIEGO, June 17, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and RayThera Inc., a private biotechnology company focused on discovering and developing small molecule ...

PHOENIX — Much of rural Arizona could soon be dotted with small "modular'' nuclear reactors. Legislation approved by the Senate and awaiting a House vote would strip supervisors in Arizona's 13 rural ...